Steven Cohen’s Day One Biopharmaceuticals DAWN Stock Holding History

Steven Cohen’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-31,938	Closed	-$685K	–	4125
2026 Q1	$685K	Sell	31,938 -124,268	-80%	-$1.75M	﹤0.01%	2977
2025 Q4	$1.46M	Buy	+156,206	New	+$1.3M	﹤0.01%	2663
2025 Q3	–	Sell	-391,280	Closed	-$2.54M	–	2386
2025 Q2	$2.54M	Buy	+391,280	New	+$2.69M	0.01%	1201
2024 Q3	–	Sell	-470,247	Closed	-$6.48M	–	2055
2024 Q2	$6.48M	Buy	+470,247	New	+$6.88M	0.02%	768
2024 Q1	–	Sell	-88,000	Closed	-$1.28M	–	2274
2023 Q4	$1.28M	Sell	88,000 -456,560	-84%	-$5.53M	﹤0.01%	1329
2023 Q3	$6.68M	Buy	544,560 +413,560	+316%	+$5.39M	0.02%	791
2023 Q2	$1.56M	Buy	+131,000	New	+$1.71M	﹤0.01%	1078
2023 Q1	–	Sell	-461,631	Closed	-$9.93M	–	2294
2022 Q4	$9.93M	Buy	+461,631	New	+$9.47M	0.03%	554

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Steven Cohen's DAWN Position: Q2 2026 in Review

Steven Cohen sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 31,938 shares — an estimated $685K sold.

Steven Cohen first reported a position in DAWN in Q4 2022 and held it in 8 quarters. The position peaked at $9.93M in Q4 2022. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Steven Cohen reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 31,938 Day One Biopharmaceuticals shares in Q2 2026, an estimated $685K.
Steven Cohen first reported a position in Day One Biopharmaceuticals in Q4 2022 and held it in 8 quarters.
Steven Cohen's Day One Biopharmaceuticals position peaked at $9.93M in Q4 2022.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.